Brainsway Dtms denied due to quantity / dose limits by Humana?
Quantity-limit denials usually flip when the appeal documents the clinically appropriate dose for the patient's weight, kidney function, or escalation schedule, citing the FDA label or specialty-society guideline.
US health-plan appeal rights
Cite: Most US health plans have appeal rights under either the ACA, ERISA, or Medicare/Medicaid rules
Most US health plans are required by federal law to give you both an internal appeal (where the insurer reconsiders) and an external review (where an independent reviewer decides). The exact timelines and processes depend on what kind of plan you have — marketplace / employer group, self-funded, Medicare Advantage, or Medicaid MCO — but in every case there's a window after the denial during which you have the right to fight it.
What Humana typically requires
Humana's specific coverage criteria for brainsway dtms are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.
The Humana angle on Brainsway Dtms
## Why Humana May Impose Quantity Limits on BrainsWay Deep TMS
Humana's quantity-limit denial for BrainsWay Deep TMS typically means the plan has approved a course of treatment but is limiting the total number of sessions, the frequency of sessions, or the number of courses of treatment in a defined time period. Deep TMS is delivered in a structured session-based protocol, and insurers' quantity limits do not always align with the clinical protocol determined to be appropriate for a given patient's presentation.
Quantity-limit denials are appealable when the clinical evidence supports that the requested quantity is medically necessary and consistent with the applicable treatment protocol for the patient's condition.
## Federal Appeal Framework
- ACA §2719 / External Review: Available for most non-grandfathered plans within approximately 4 months (180 days) of denial. Expedited review is available if an ongoing course of treatment is being interrupted or delayed.
- Mental Health Parity (MHPAEA): Limits applied to mental health treatments must be comparable to limits applied to analogous medical/surgical procedures. If Humana's quantity limits for Deep TMS are more restrictive than limits for comparable medical procedures, a parity argument may apply.
- ERISA §503: Entitles you to the specific quantitative criteria used and a full-and-fair review of the quantity determination.
## Appeal Process and Timeline
1. Request the basis for the quantity limit — Humana must identify the specific coverage policy language or clinical criterion supporting the limit imposed. 2. Identify the clinical need for additional sessions — your prescriber should document why the approved quantity is clinically insufficient for this patient. 3. Internal appeal — file within Humana's deadline with clinical documentation supporting the requested quantity. Standard review is up to 30 days; urgent is 72 hours. 4. External review — available after internal denial, with an independent clinical reviewer evaluating the quantity determination.
## Documentation to Gather
- Prescriber's protocol rationale: A letter from the treating clinician explaining the recommended number of sessions, why this specific patient requires the full requested quantity, and how this aligns with the applicable treatment protocol.
- Clinical progress documentation: If sessions are already underway, chart notes documenting the patient's response trajectory and the clinical basis for continuing or extending treatment.
- Diagnosis and severity documentation: Current clinical status, supporting the ongoing need.
- Humana policy language: The exact limit cited, so you can address whether it applies to this clinical scenario.
- Parity evidence (if applicable): Examples of comparable quantity authorizations for analogous medical procedures covered by the plan.
## Criteria-Mapping Structure
| Quantity Limit Basis | Appeal Response | |---|---| | Policy limit on number of sessions | [Prescriber letter explaining medical necessity for requested number] | | Policy limit on retreatment courses | [Clinical documentation of current presentation and prior outcomes] | | Frequency restriction | [Clinical rationale for prescribed schedule] | | Parity comparison (if raised) | [Comparable medical procedure limits under the plan] |
Obtain the current version of Humana's Deep TMS coverage policy and the FDA-cleared protocol parameters for BrainsWay before filing. The prescriber's letter should specifically address the quantity criteria in Humana's policy.
Next steps
- Find the date on the denial letter — your appeal window starts there.
- Read your plan's Summary of Benefits and Coverage (SBC) for the specific deadlines.
- Request the insurer's claim file in writing — they must provide it.
- Submit your appeal in writing with new clinical evidence and a physician statement.
Get the letter drafted
DenialHelp drafts your appeal in 5 minutes — $40 list price, $30 for your first letter (use code SEO25). We cite the federal regs and the specific clinical evidence your plan responds to. Your physician signs and sends.
Start my appeal — $30 with code SEO25 →